SSRIs, SNRIs, NRIs, NDRIs, and SNDRIs ...

Serotonin reuptake inhibitors, particularly selective agents (SSRIs), are widely employed in the management of mood disorders and are increasingly recognised for their effects on blood clotting ...

LOS ANGELES — The novel norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI) centanafadine (Otsuka Pharmaceutical Co., Ltd.) is effective and ...

“To our knowledge, this is the first systematic assessment of the long-term effects of commonly used antidepressants on cognition in patients with dementia,” wrote co-corresponding authors Sara Garcia ...

Shandong Quanzhong Biomedical Technology Co. Ltd. has synthesized monoamine transmitter reuptake inhibitors reported to be useful for the treatment of neurological disorders, depression, autism, pain, ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of ...

A collage of a ball-and-stick model of a serotonin molecule, a sad-looking person, some drug capsules, and a brain Credit: Shutterstock/Madeline Monroe/C&EN For decades, doctors, neuroscientists, and ...

Immediately following Robert F. Kennedy Jr.’s confirmation as health secretary, President Donald Trump instructed his administration to assess the “threat” posed to children by the prescription of ...

A small class of older antidepressants demands strict food rules many patients are never fully briefed on. The post If you ...

Reuptake inhibitors are a type of drug used to treat depression, anxiety, and other psychiatric conditions. They work by preventing neurotransmitters—the body’s chemical messengers—from being ...